*By Lauren Babbage*
A two-day meeting of the the Federal Reserve's Open Market Committee was to begin Tuesday, when central bank officials will consider a potential second rate hike this year.
There are a number of challenges the committee will face, in addition to an uptick in inflation. The economy may be near full employment, but wages haven't increased. The country's fiscal spending, according to the Congressional Budget Office, may increase the national debt as a percent of GDP to a higher level than Italy in five years.
One might expect to see the economy pullback, but that's not been the case.
"It's like 2 A.M., everyone has been partying all night, and the federal government comes out and goes, 'No no, we're going to keep going for a lot more hours' and now the Fed has to try to keep everyone healthy," said Lenore Hawkins, the chief macro strategist at Tematica Research. "That's like, alright, start doing the shots of espresso, but the Fed is trying to keep everyone from getting the jitters. This is not an easy thing for them to do."
Investors were spooked last week when the 10-year Treasury note hit 3 percent for a brief period, and Hawkins said that nervousness will continue.
The market is seeing a decrease in liquidity, which means an increase in volatility, she said. That is heightened by the increasing debt of the U.S. Treasury.
For full interview, [click here](https://cheddar.com/videos/the-fed-interest-rate-face-off).
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
